In this regard, unraveling changes in TRPV4 channel expression and activity in cerebral arterial muscle pathologies of humans and animal disease models may lead to the development of TRPV4 channel targeted therapeutics to manage associated functional disorders of the cerebral circulation. Here, TRPV4 is linked to non-human animal disease.